Go to Page # Page of 29
loading

Merus Pioneering Bispecific Antibodies By Jefferies Financial

 Jefferies Financial Group Inc.
  23rd-Aug-2019
Description: Merus Pioneering Bispecific Antibodies offers bispecific antibodies novel modes of action & new biology referred to Biclonics, based on full-length IgG format.
Views: 1453
Domain: Medical
Category: Biotech/Pharma
Contents:
Pioneering Bispecific Antibodies
June 4, 2019

Disclaimer
This presentation (including any oral commentary that accompanies this
presentation) contains forward-looking statements within the meaning of the
Private Securities Litigation Reform Act of 1995. All statements contained in this
presentation that do not relate to matters of historical fact should be considered
forward-looking statements, ... See more

Recent Presentations

...
17 September, 2019

IMAP Medical Devices

Here describe the IMAPs experience in healthcare buy-side advisory and deep knowledge of the industry were key factors in successfully closing the transaction.

IMAP
16 September, 2019
PFCD
15 September, 2019